Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.
Other companies in Pliant Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Terns Pharma (NASDAQ:TERN) and Neumora Therapeutics (NASDAQ:NMRA).
Pliant Therapeutics has a consensus price target of $24.42.
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $3.17 last updated February 26, 2025 at 4:14 AM EST.
There are no upcoming dividends for Pliant Therapeutics.
Pliant Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Pliant Therapeutics.
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.